- By 2026, this collaboration would enable about 650,000 million British thermal units (190,500 megawatt-hours) of Renewable Natural Gas across AstraZeneca’s US sites yearly.
- The partnership between AstraZeneca and Vanguard Renewables is due to the companies’ respective industries shared decarbonisation goal.
AstraZeneca (AZN) and Vanguard Renewables have announced a partnership to enable the delivery of renewable natural gas (RNG) to all of AZN’s US sites by the end of 2026. The Chief Executive Officer of Vanguard Renewables’, Neil H. Smith, disclosed this to Bioenergy Insight.
Since June this year, AZN started purchasing renewable natural gas produced by Vanguard Renewables for its Newark Campus in Delaware. This is where the firm packages 26 medicines for distribution across the United States and makes medicine formulations for global supply. By 2026, this collaboration would enable about 650,000 million British thermal units (MMBtu), or 190,500 megawatt-hours (MWh), per year of RNG across AstraZeneca’s United States sites. This is equivalent to the energy required to heat more than 17,800 US homes annually.
According to Smith, the partnership between the two companies came about because the companies’ respective industries (food and beverage, dairy farming and pharmaceuticals) have a shared decarbonisation goal. “AstraZeneca has set very aggressive sustainability goals and is working hard to achieve them,” noted Smith.”